Kolkata: Drug Trafficker Wanted For Smuggling 14,998 Cough Syrup Bottles Nabbed By NCB

Kolkata:  The Narcotics Control Bureau (NCB) Kolkata arrested a notorious drug trafficker with a history of gold smuggling wanted in a seizure of a huge quantity of bottles of Codeine Based Cough Syrups (CBCS), officials said on Saturday.

As per a release, in one of the most challenging anti-drug operations regarding interception of illicit trafficking of Codeine Based Cough Syrups (CBCS) destined to Bangladesh, NCB Kolkata has, on November 13, 2024 arrested an International drug trafficker namely Gautam Mondal from Kolkata who was wanted in a seizure of 14,998 bottles of GBCS (brand name Phensedyl) of NCB Kolkata.

NCB said that Gautam Mondal is a notorious drug trafficker with a history of Gold smuggling. “He has 3 known cases of DRI regarding smuggling of huge quantities of Gold worth Crores. He had also clutched his claws upon the illicit trafficking of CBCS routed through West Bengal and destined to Bangladesh. Gautam Mondal is a long-time wanted habitual offender in 3 known NDPS cases of STF West Bengal,” the NCB said.

The NCB further said that the seized CBCS in the case of NCB Kolkata were sourced from Uttar Pradesh and illegally diverted from legal channels.

“Gautam Mondal is hard core NDPS offender whose modus operandi is to work in several layers. He has trained several of his henchmen to work in pairs for a particular set of duties and keeps on changing them so as to avoid detection by drug law enforcement agencies,” NCB further added.

NCB said that Gautam’s arrest is a significant blow on the functioning of his whole drug trafficking organization which he was running from the top. “Investigation to identify and apprehend his aides is on. Joint Interrogation with DRI Kolkata and STF West Bengal will be done to dismantle his organized crime syndicate,” NCB added.

Related Posts

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Gujarat based Senores Pharmaceuticals Ltd on Monday, December 15, announced that it has entered into a share purchase agreement to acquire a 100% equity stake in Apnar Pharma Private Ltd.…

Aytu BioPharma launches depression drug EXXUA in U.S. market

DENVER-  Aytu BioPharma, Inc. (NASDAQ:AYTU) announced Monday the commercial availability of EXXUA in the United States for the treatment of major depressive disorder (MDD). The small-cap biotech, with a market…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

ITS in AMTZ, 70 Countries participated for Future of Health Technology

ITS in AMTZ, 70 Countries participated for Future of Health Technology

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session

Glenmark Pharmaceuticals Ltd soars 0.2%, gains for fifth straight session